TIANJIN, China, May 14, 2015 /PRNewswire/ -- Five Nobel Prize Laureate's and the world's top scientists met this week in Tianjin, China, for an unprecedented Summit, exchanging research data, advances, and promising projections related to the prevention, identification, diagnosis, and treatment of cancer worldwide. Known as the, "2015 Nobel Prize Laureate Summit on Biomedical Science: Frontiers in Cancer Research," Summit organizers declared the event's mission: "To bring the world's most eminent scientists together to China, to both organize and improve collaborative efforts with their counterparts; as well as inspire a new generation of young students and scientists creating innovative solutions to cancer treatment and cures."
"There are few diseases that bring more fear upon diagnosis," explains Sir Richard Roberts, 1993 Nobel Laureate in Physiology/Medicine, 2015 NPLS ConferenceBoard Director, and the initiator of the Summit. "And despite 50 years of fighting the 'War on Cancer' declared by President Nixon, progress has been disappointing - until recently. Now are we are beginning to see the realization of long-anticipated immunological treatments that may herald the age of truly personalized medicine. The next hurdle will be to overcome the regulatory challenges of making sure that such procedures are done safely."
Such a prominent and important meeting of international researchers and scientists in one event was possible due to the joint cooperation of a multi-national coalition representing Nobel researchers, medical community, private companies/institutions, and academic leaders, including NPLS organizers: International Society of Scientific Communications for Nobel Prize Laureates; Massachusetts General Hospital Cancer Center; the Chinese Anti-Cancer Association; China International Conference Center for Science; and Technology World Nobel Medical Media Co Ltd.; among others.
States Jiong Wu, Executive Director, Richard J. Roberts Institute of Biotechnology Secretary-General, 2015 Nobel Prize Laureate Summit Organizing Committee, "During the past few years, great progress has been made in combating cancer from basic studies to clinical treatments, including advances in cancer cell signaling, cancer genomics, big data analysis in cancer, precision and targeted therapy, checkpoint antibody drugs, and Car-T immunotherapy, etc. We invited the top scientists working in various aspects of this field to present their state-of-art studies at this Summit meeting and discuss new directions for future studies."
For more information regarding the NPLS, please check: http://www.nobelsummit.com/en/news.asp?id=35.html.
SOURCE Anpac Bio-Medical Science Company, Ltd.